Département de chimie moléculaire

67Cu-Radiolabeling of a multimeric RGD peptide for αVβ3 integrin-targeted radionuclide therapy: stability, therapeutic efficacy, and safety studies in mice., Jin, Zhao-hui, Furukawa Takako, Ohya Tomoyuki, Degardin Melissa, Sugyo Aya, Tsuji Atsushi B., Fujibayashi Yasuhisa, Zhang Ming-Rong, Higashi Tatsuya, Boturyn Didier, et al. , Nucl. Med. Commun., Volume 38, Number 4, p.347–355, (2017)

$\alpha$V$\beta$3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4., Jin, Zhao-hui, Furukawa Takako, Degardin Melissa, Sugyo Aya, Tsuji Atsushi B., Yamasaki Tomoteru, Kawamura Kazunori, Fujibayashi Yasuhisa, Zhang Ming-Rong, Boturyn Didier, et al. , Mol. Cancer Ther., Volume 15, Number 9, p.2076–2085, (2016)

Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer, Jin, Zhao-hui, Tsuji Atsushi B., Degardin Melissa, Sugyo Aya, Obara Satoshi, Wakizaka Hidekatsu, Nagatsu Kotaro, Hu Kuan, Zhang Ming-Rong, Dumy Pascal, et al. , Clinical Cancer Research, 09/2020, Volume 26, Issue 23, p.6230-6241, (2020)

Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model., Jin, Zhao-hui, Tsuji Atsushi B., Degardin Melissa, Sugyo Aya, Yoshii Yukie, Nagatsu Kotaro, Zhang Ming-Rong, Fujibayashi Yasuhisa, Dumy Pascal, Boturyn Didier, et al. , EJNMMI Res., Volume 8, Number 1, p.1–10, (2018)